Amphix Bio, Inc. funding
Amphix Bio, Inc., a biotechnology company based in Chicago, IL, filed a Form D with the SEC on December 19, 2025 and reported $10.3M raised of a $12.5M offering.
Amount raised$10.3M
Offering size$12.5M
Filed with the SECDecember 19, 2025
First saleDecember 4, 2025
IndustryBiotechnology
SecuritiesEquity
LocationChicago, IL
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far9
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Dec 19